Table 2.
The Value of nMxa, BP-CI and CBFV-CI During Three Stages of TTT
| Subject | Stage 1 | Stage 2 | Stage 3 | ||||||
|---|---|---|---|---|---|---|---|---|---|
| nMxa | BP-CI | CBFV-CI | nMxa | BP-CI | CBFV-CI | nMxa | BP-CI | CBFV-CI | |
| Normal | -0.200±0.123 | 3.882±0.289 | 4.314±0.557 | -0.203±0.112 | 4.749±0.748 | 5.003±0.715 | -0.200±0.085 | 3.943±0.317 | 4.075±0.593 |
| Patients | 0.145±0.477 | 2.542±1.720 | 4.621±1.404 | 0.334±0.338 | 3.377±0.879 | 5.501±2.215 | 0.356±0.353 | 3.758±1.440 | 5.552±2.002 |
| P value | 0.181 | 0.150 | 0.682 | 0.0078 | 0.013 | 0.6716 | 0.008 | 0.806 | 0.176 |
Note: nMxa is the Pearson correlation coefficient between BP and CBFV, BP-CI is the CI of BP and CBFV-CI is the CI of CBFV.